Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anke Schulz

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2021
Performing Meta-analyses with Very Few StudiesAnke Schulz, Christoph Schürmann, Guido Skipka, et al.
Genetic Epidemiology|February 13, 2010
Entropy-supported marker selection and Mantel statistics for haplotype sharing analysisAnke Schulz, Christine Fischer, Jenny Chang-Claude, et al.
Nature Reviews. Drug Discovery|March 7, 2015
Sharing pharma compounds with academia: experiences with providing vitamin D receptor ligandsArndt A Schmitz, Sandra Hackethal, Anke Schulz, et al.
BMC Proceedings|December 19, 2009
Representation of genetic association via attributable familial relative risks in order to identify polymorphisms functionally relevant to rheumatoid arthritisJusto Lorenzo Bermejo, Christine Fischer, Anke Schulz, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 14, 2013
Cytokeratin-19 as a biomarker in urine and in serum for the diagnosis of endometriosis--a prospective studyLorenz Kuessel, Agnes Jaeger-Lansky, Petra Pateisky, et al.
BMC Cancer|August 13, 2016
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detectionMarion Rudolph, Tobias Anzeneder, Anke Schulz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|January 28, 2020
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT TrialPaulus Kirchhof, Michael D Ezekowitz, Yanish Purmah, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2019
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Annals of Medicine|June 30, 2018
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)Kazuo Miyazawa, Daniele Pastori, Christoph Hammerstingl, et al.
Therapeutic Innovation & Regulatory Science|December 10, 2020
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2021
Performing Meta-analyses with Very Few StudiesAnke Schulz, Christoph Schürmann, Guido Skipka, et al.
Genetic Epidemiology|February 13, 2010
Entropy-supported marker selection and Mantel statistics for haplotype sharing analysisAnke Schulz, Christine Fischer, Jenny Chang-Claude, et al.
Nature Reviews. Drug Discovery|March 7, 2015
Sharing pharma compounds with academia: experiences with providing vitamin D receptor ligandsArndt A Schmitz, Sandra Hackethal, Anke Schulz, et al.
BMC Proceedings|December 19, 2009
Representation of genetic association via attributable familial relative risks in order to identify polymorphisms functionally relevant to rheumatoid arthritisJusto Lorenzo Bermejo, Christine Fischer, Anke Schulz, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 14, 2013
Cytokeratin-19 as a biomarker in urine and in serum for the diagnosis of endometriosis--a prospective studyLorenz Kuessel, Agnes Jaeger-Lansky, Petra Pateisky, et al.
BMC Cancer|August 13, 2016
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detectionMarion Rudolph, Tobias Anzeneder, Anke Schulz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|January 28, 2020
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT TrialPaulus Kirchhof, Michael D Ezekowitz, Yanish Purmah, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2019
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Annals of Medicine|June 30, 2018
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)Kazuo Miyazawa, Daniele Pastori, Christoph Hammerstingl, et al.
Therapeutic Innovation & Regulatory Science|December 10, 2020
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Pageof 2